SQZ Biotechnologies is a biotech company that develops cell therapies for cancer, autoimmune, infectious diseases, and other serious conditions. Their lead product candidate, SQZ-PBMC-HPV, is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors. The company also develops other treatment options and has additional platforms in development.